ReviewAging by epigenetics—A consequence of chromatin damage?
Introduction
As reviewed in this volume and elsewhere, organismal longevity and aging may be influenced by many complex interacting factors [1]. These include accumulation of nuclear and mitochondrial genome mutations; shortened and dysfunctional chromosome telomeres; oxidative damage of DNA and other macromolecules; systemic hormonal factors, such as insulin/IGF signaling; and senescence, apoptosis and altered differentiation in self-renewing tissues that depend on stem cells. In many cases, these factors are, or are likely to be, overlapping and/or interacting. In this chapter, we discuss another possible determinant of aging, “epigenetics”.
Strictly speaking, “epigenetics” refers to chromatin and DNA modifications that are heritable through cell division, but do not involve changes in the underlying DNA sequence [2]. However, since the aging process is not restricted to proliferating tissues and may, in fact, be influenced by irreversible proliferation arrest, we will use the term more loosely to refer to effects mediated by chromatin structure and DNA methylation, but not DNA sequence.
Section snippets
The dynamic and stochastic properties of chromatin
The basic repeating unit of chromatin structure is the nucleosome, comprised of about 146 bp of DNA wrapped around an octamer of histones [3]. Chromatin can be broadly divided into two types, heterochromatin and euchromatin [4]. Euchromatin is decondensed during interphase, relatively transcriptionally active and replicates early in S-phase. Conversely, heterochromatin remains condensed during interphase, is more transcriptionally silent and is late replicating. Heterochromatin is itself
Aging is associated with epigenetic changes, from yeast to humans
The enzymes that add and remove acetyl groups, the histone acetyltransferases (HATs) and histone deacetylases (HDACs) respectively, determine the steady-state level of histone acetylation [10]. In Saccharomyces cerevisiae, inactivation of the histone deacetylase, Sir2, shortens replicative lifespan [20], [21], [22]. Conversely, activation of Sir2 extends lifespan. The anti-aging effects of Sir2 in yeast are, at least in part, due to translocation of a Sir2-containing protein complex from
Cellular senescence is associated with redistribution of heterochromatin
Cellular senescence is characterized by an irreversible proliferation arrest [60]. Cellular senescence can be initiated by various triggers, including an excessive number of cell divisions, in part due to shortened chromosome telomeres (so-called replicative senescence). Because of senescence, most primary human cells have a finite proliferative lifespan, and evidence has been presented that senescence contributes to tissue aging in vivo, in part by limiting the self-renewal of tissues [61],
Progeria cells exhibit accelerated changes in chromatin
Hutchinson–Gilford Progeria Syndrome (HGPS) is a rare syndrome that is characterized by rapid onset of some debilitating phenotypes that are typically indicative of aging [95]. These include severe growth retardation, loss of subcutaneous fat, alopecia, reduced bone density and poor muscle development. The average age of death in HGPS is 12–15 years, usually by myocardial infarction or stroke. However, HGPS patients do not accelerate all aspects of aging. For example, cancer incidence is rare
The consequences of age-associated epigenetic changes
Not surprisingly, the consequence of these age-associated epigenetic changes is best understood in yeast. As discussed above, in this organism redistribution of Sir2 and heterochromatic proteins counteracts the aging process [21], [22]. The consequence of the various modes of age-associated epigenetic regulation in mammals remains somewhat speculative. However, aging is accompanied by various altered phenotypes that might be linked to age-associated epigenetic changes. Studies going back to the
Summary, outstanding questions and therapeutic implications
From the preceding discussion, it is apparent that chromatin structure does change with aging, in organisms as diverse as yeast and mammals. However, with the exception of Sir2 in yeast, the extent to which this impacts the aging process has not yet been defined. Although it is early days for this field, we propose that some age-associated epigenetic alterations in mammals, such as formation of SAHF, might extend lifespan by suppressing age-associated diseases, such as cancer. However, as
Acknowledgments
PDA is supported by the NIH (RO1 GM062281, P01 AG031862 and R01 CA129334-01) and is a scholar of the Leukemia and Lymphoma Society. JMS is supported by the NIH (R01 GM041690 and R01 AG016694), and a Senior Scholar Award from the Ellison Medical Foundation. PDA thanks members of the Adams lab as well as Shelley Berger, Ronen Marmorstein and Brad Johnson for discussions.
References (118)
Understanding the odd science of aging
Cell
(2005)- et al.
Epigenetics: a landscape takes shape
Cell
(2007) Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome
Curr. Opin. Genet. Dev.
(2005)Chromatin modifications and their function
Cell
(2007)- et al.
Unravelling heterochromatin: competition between positive and negative factors regulates accessibility
Trends Genet.
(2002) - et al.
Chromatin challenges during DNA replication and repair
Cell
(2007) - et al.
A chromatin landmark and transcription initiation at most promoters in human cells
Cell
(2007) - et al.
Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects
Cell
(2002) - et al.
Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae
Cell
(1995) - et al.
Sirtuins in aging and age-related disease
Cell
(2006)